Creating Better Medicines through Better Conjugation

Publication
Article
BioPharm InternationalBioPharm International-12-16-2013
Volume 2013 eBook
Issue 1

Clinical-stage biopharmaceutical company Ambrx leverages its site-specific bioconjugation technology through partnerships.

 

Clinical-stage biopharmaceutical company Ambrx leverages its site-specific bioconjugation technology through partnerships to bring drugs with enhanced stability and bioactivity to market.

Read this article

from BioPharm International’s 2013 Innovation Updates and Strategies eBook.

 

 

 

 

 

 

 

Recent Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.